Nephros

$6.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-2.10%) Today
+$0.12 (+1.98%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Nephros and other stocks, options, and ETFs commission-free!

About NEPH

Nephros, Inc. Common Stock, also called Nephros, is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ. The listed name for NEPH is Nephros, Inc. Common Stock.

CEO
Andrew Astor
Employees
25
Headquarters
South Orange, New Jersey
Founded
1997
Market Cap
59.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
25.78K
High Today
$6.35
Low Today
$5.94
Open Price
$6.14
Volume
4.53K
52 Week High
$10.80
52 Week Low
$4.42

Collections

NEPH Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, After Hours

You May Also Like